An image showing covid vaccines

Pharmaceuticals roundup 2021

2021-12-16T15:02:00+00:00

It’s been another dramatic, pandemic-dominated year for the pharmaceutical industry

An image showing capsules of Molnupiravir

Covid-19 antivirals surge forward

2021-11-12T14:17:00+00:00

Promising results from Pfizer trial, while UK approves Merck & Co’s molnupiravir

An image showing viral RNA replication

New antiviral impresses against Covid-19

2021-10-08T13:28:00+01:00

Merck & Co and Ridgeback’s molnupiravir reduces risk of hospitalisation and death, and may work against other coronaviruses

The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics

Introduction: the coronavirus pandemic and the future

This series of Chemistry World reports is part of a forth coming e-book and hardback to be published by the Royal Society of Chemistry. The book was motivated by a desire on the part of the editors and the authors to produce a body of information on the new and deadly coronavirus about which the world was largely uninformed and for which it was totally unprepared. 

Shinagawa station in busy morning rush hour

Favipiravir

2020-07-31T22:10:00+01:00By

Originally developed to treat flu and marketed in Japan as Avigan, promising Covid-19 trial results have seen countries stockpiling this medication by the millions

Source:  © StreetVJ / Shutterstock.com